This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks to Watch: Cisco, BlackBerry, Macy's

NEW YORK -- Cisco Systems (CSCO - Get Report) is expected by Wall Street on Wednesday to report fiscal third-quarter earnings of 49 cents a share on revenue of $12.18 billion, which would represent sales growth of 5%.

The networking giant has strung together eight consecutive quarterly earnings beats.

Cisco's Still a Strong Buy Ahead of Earnings


BlackBerry (BBRY - Get Report) shares fell almost 4% on Tuesday to $15.25 after the smartphone maker unveiled a new operating system and a new lower-priced handset at its annual conference for investors and developers in Orlando, Fla.

The stock had risen 34% before Tuesday.

BlackBerry also said it would offer its BlackBerry Messenger service on iPhones and devices running Google's (GOOG - Get Report) Android software.

BlackBerry Falls on Q5 Smartphone News


Google's annual software developers' conference, dubbed "Google I/O," begins Wednesday in San Francisco, and the Internet giant is expected to showcase the latest mobile devices running on Android, which has been activated on more than 750 million devices around the world.

Google is reportedly expected to unveil an upgrade to the Nexus 7, a mini-tablet that debuted at the event last year.

Samsung Galaxy S4 Review: The Best Android That's Not Nexus


Macy's (M - Get Report), the retailer, is expected by analysts to post first-quarter earnings of 53 cents a share on sales of $6.39 billion.


Shares of Myriad Genetics (MYGN - Get Report) rose 4% to $34.10 on Tuesday after it was revealed that actress Angelina Jolie recently had a preventative double mastectomy after learning she faced a high risk of breast and ovarian cancer because of an inherited genetic mutation. Myriad makes a BRACAnalysis test that looks for that mutation, and the test is the source of most of the company's revenue.


-- Written by Joseph Woelfel



>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

Copyright 2013 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
BBRY $10.27 0.00%
CSCO $29.13 0.00%
GOOG $537.90 0.00%
M $65.07 0.00%
MYGN $34.18 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs